PLE-2248
JA was suspected of having a hematologic malignancy. Analysis showed that he has a t(9:22) translocation, forming a fusion product called bcr abl. What is the treatment for this case?
JA was suspected of having a hematologic malignancy. Analysis showed that he has a t(9:22) translocation, forming a fusion product called bcr abl. What is the treatment for this case?